Back to Search
JOSEPH TROJAN, M.D.
M.D.
Internal Medicine Physician
NPI: 1225022700Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
26061(WI)
Research & Publications (20)
Adenoma development in a patient with MUTYH-associated polyposis (MAP): new insights into the natural course of polyp development.
PMID 19672709·Dig Dis Sci·2010
5-case
An interstitial deletion at 3p21.3 results in the genetic fusion of MLH1 and ITGA9 in a Lynch syndrome family.
PMID 19188145·Clin Cancer Res·2009
8-other
Independent psychophysical measurement of experimental modulations in the somatotopy of cutaneous heat-pain stimuli.
PMID 19283552·Somatosens Mot Res·2009
8-other
Cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study.
PMID 19293797·Br J Cancer·2009
3-trial
Tactile-auditory saltation: spatiotemporal integration across sensory modalities.
PMID 19477228·Neurosci Lett·2009
8-other
Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth.
PMID 19637194·Hepatology·2009
7-preclinical
Neoadjuvant treatment with cetuximab, 5-Fluorouracil, folinic Acid and oxaliplatin in unresectable retroperitoneal recurrent colon cancer.
PMID 18759201·Z Gastroenterol·2008
8-other
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial.
PMID 18182984·Br J Cancer·2008
3-trial
Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation.
PMID 17311050·Eur J Clin Nutr·2008
8-other
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.
PMID 18585385·Gastroenterology·2008
3-trial
Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?
PMID 17339249·Gut·2007
8-other
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers.
PMID 17364234·Invest New Drugs·2007
3-trial
A new putative target for antisense gene therapy of glioma: glycogen synthase.
PMID 17426442·Cancer Biol Ther·2007
7-preclinical
Insulin-like growth factor type I biology and targeting in malignant gliomas.
PMID 17320297·Neuroscience·2007
6-review
Stimulation of anti-melanoma immune effectors via modified tumour cells exhibiting inhibited IGF-I and low CD9.
PMID 17764889·Biomed Pharmacother·2007
7-preclinical
Thymosin beta 4 expression and nuclear transport are regulated by hMLH1.
PMID 17967441·Biochem Biophys Res Commun·2007
8-other
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.
PMID 17229775·Ann Oncol·2007
3-trial
Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome.
PMID 16463052·Eur J Pediatr·2006
5-case
Psychophysical 'perceptual maps' of heat and pain sensations by direct localization of CO2 laser stimuli on the skin.
PMID 16982038·Brain Res·2006
4-observational
The saltation illusion demonstrates integrative processing of spatiotemporal information in thermoceptive and nociceptive networks.
PMID 16328290·Exp Brain Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2500 W LAYTON AVE, SUITE 250
MILWAUKEE, WI 53221 - Phone
- (414) 282-2006
Quick Facts
- NPI
- 1225022700
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile